Powder: -20°C for 3 years | In solvent: -80°C for 1 year
STX-478 (compound 80), an orally administered, CNS-penetrant allosteric mutant-selective PI3Kα inhibitor, demonstrates significant and sustained tumor regression, making it a valuable agent in cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | STX-478 (compound 80), an orally administered, CNS-penetrant allosteric mutant-selective PI3Kα inhibitor, demonstrates significant and sustained tumor regression, making it a valuable agent in cancer research [1]. |
Molecular Weight | 401.29 |
Formula | C16H12F5N5O2 |
CAS No. | 2883540-92-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
STX-478 2883540-92-7 PI3K/Akt/mTOR signaling PI3K inhibitor inhibit